Drug intelligence / Profile preview

rice bran arabinoxylan

Development stage
Unknown
Lead developer
Daiwa Pharmaceutical
Administration
Oral
01

Overview

Rice bran arabinoxylan compound (RBAC) is a heteropolysaccharide nutraceutical derived from the enzymatic hydrolysis of defatted rice bran using enzymes from *Lentinus edodes* (shiitake mushroom) mycelia. It functions as a natural immunomodulator, primarily by enhancing natural killer (NK) cell activity and modulating the secretion of cytokines such as tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ). Developed by Daiwa Pharmaceutical, it is most commonly known by the brand name Biobran (MGN-3). RBAC has been investigated as a complementary therapy for various conditions, including hepatocellular carcinoma, multiple myeloma, HIV infection, and metabolic disorders like diabetes and nonalcoholic fatty liver disease. It is classified as a functional food or dietary supplement rather than a conventional pharmaceutical drug.

Brand names
BiobranRBAC
Other names
rice bran arabinoxylan compoundarabinoxylan rice branRBAC
02

Targets

IFNG (Interferon gamma)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on rice bran arabinoxylan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rice bran arabinoxylan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call